The curious tale of Eurocann’s journey to ASX listing by Steve Jones November 10, 2022April 29, 2024 EXCLUSIVE: Privately-owned Australian cannabis firm Eurocann is preparing to list on the ASX with ambitions to […]
Ananda Clinics goes local as it seeks to persuade ‘middle Australia’ that cannabis is a medicine by Steve Jones November 10, 2022April 29, 2024
Survivors of dotcom boom and bust keep us focused, says Althea boss after share price slump by Steve Jones November 4, 2022April 29, 2024
Althea plots cost cutting and announces A$4m capital raise to shore up finances by Steve Jones November 3, 2022April 29, 2024
TGA reminds industry to follow product recall guidelines by Martin Lane November 3, 2022November 3, 2022
Epsilon to end Valens deal as firm remains under financial strain by Steve Jones November 1, 2022April 29, 2024
Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI by Martin Lane and Steve Jones November 1, 2022April 29, 2024
TGA issues more heavy fines as advertising crackdown gathers pace by Martin Lane October 31, 2022April 29, 2024
ECS puts hold on new flower customers to avoid demand outstripping supply by Steve Jones October 27, 2022April 29, 2024
